Live
ePaper
Search
Home > Business > J&J strikes $2.2 billion buyout deal for eye disease biotech Ollin Biosciences

J&J strikes $2.2 billion buyout deal for eye disease biotech Ollin Biosciences

Written By:
Last Updated: November 16, 2026 19:04:52 IST

Nov 16 (Reuters) – Johnson & Johnson said on Monday it had agreed to buy Texas-based biotech Ollin Biosciences, expanding its pipeline of eye disease therapies. Johnson & Johnson will acquire Ollin

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?